Keokia Leora Mendiola, MA, CCC-SLP | |
111 San Carlos Lane, Asan, GU 96922 | |
(671) 482-4845 | |
Not Available |
Full Name | Keokia Leora Mendiola |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 111 San Carlos Lane, Asan, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366773806 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 18655 (California) | Secondary |
235Z00000X | Speech-language Pathologist | SLA-051 (Guam) | Primary |
Mailing Address | Practice Location Address |
---|---|
Keokia Leora Mendiola, MA, CCC-SLP Po Box 1947, Hagatna, GU 96932-1947 Ph: (671) 482-4845 | Keokia Leora Mendiola, MA, CCC-SLP 111 San Carlos Lane, Asan, GU 96922 Ph: (671) 482-4845 |
News Archive
By combining a quantum dot with a novel carrier of the magnetic resonance imaging (MRI) agent gadolinium, a team of investigators at the University of Maastricht, in The Netherlands, has developed a nanoparticle that can spot apoptosis, or programmed cell death, using both MRI and fluorescence imaging.
It's about the size of a large vitamin pill and, for the first time in Ohio, the smallest heart pacemaker available is being tested at The Ohio State University Wexner Medical Center.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
A large survey of women in California shows significant racial and ethnic differences in the types of personal care products women use on a daily basis.
A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have developed a novel indirect screener that identifies women at risk for drug use by evaluating correlates of illicit drug use rather than drug use itself. In phase I testing, this new screener proved to be more sensitive than any alternative approach at detecting recent drug use.
› Verified 2 days ago